In last trading session, NRX Pharmaceuticals Inc (NASDAQ:NRXP) saw 1.41 million shares changing hands with its beta currently measuring 1.23. Company’s recent per share price level of $1.54 trading at -$0.1 or -5.79% at ring of the bell on the day assigns it a market valuation of $18.68M. That closing price of NRXP’s stock is at a discount of -375.97% from its 52-week high price of $7.33 and is indicating a premium of 28.57% from its 52-week low price of $1.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.28 million shares which gives us an average trading volume of 162.39K if we extend that period to 3-months.

For NRX Pharmaceuticals Inc (NRXP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.29 in the current quarter.

NRX Pharmaceuticals Inc (NASDAQ:NRXP) trade information

Upright in the red during last session for losing -5.79%, in the last five days NRXP remained trading in the green while hitting it’s week-highest on Wednesday, 12/18/24 when the stock touched $1.54 price level, adding 16.76% to its value on the day. NRX Pharmaceuticals Inc’s shares saw a change of -66.41% in year-to-date performance and have moved 29.83% in past 5-day. NRX Pharmaceuticals Inc (NASDAQ:NRXP) showed a performance of 18.85% in past 30-days. Number of shares sold short was 0.68 million shares which calculate 4.8 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 2 to the stock, which implies a rise of 23.0% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 2. It follows that stock’s current price would drop -29.87% in reaching the projected high whereas dropping to the targeted low would mean a loss of -29.87% for stock’s current value.

NRX Pharmaceuticals Inc (NRXP) estimates and forecasts

Statistics highlight that NRX Pharmaceuticals Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -46.72% of value to its shares in past 6 months, showing an annual growth rate of 52.70% while that of industry is 16.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

And 1 analysts are in estimates of company making revenue of 5M in the next quarter.

NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s Major holders

Insiders are in possession of 23.56% of company’s total shares while institution are holding 6.05 percent of that, with stock having share float percentage of 7.92%. Investors also watch the number of corporate investors in a company very closely, which is 6.05% institutions for NRX Pharmaceuticals Inc that are currently holding shares of the company.